A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis. Goodman AD, Brown TR, Schapiro RT, Klingler M, Cohen R, Blight AR Int J MS Care. 2014 Fall; 16(3):153-60. PMID: 25337058. Abstract CommentRecommendBookmarkWatch